Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Vir Biotechnology, Inc. Common Stock

VIR Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of VIR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
VIR Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
VIR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
VIR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in VIR holdings by institutional investors

Quarterly net insider trading by VIR's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $50,000 Jul 20, 2026 Issue: Health Issues
  • $50,000 Apr 19, 2026 Issue: Health Issues
  • $50,000 Jan 17, 2026 Issue: Health Issues
  • $50,000 Oct 18, 2025 Issue: Health Issues
  • $50,000 Jul 18, 2025 Issue: Health Issues
  • $50,000 Apr 16, 2025 Issue: Health Issues
  • $50,000 Jan 19, 2025 Issue: Health Issues Government Issues Budget/Appropriations
  • $50,000 Oct 18, 2024 Issue: Budget/Appropriations Government Issues Health Issues
  • $50,000 Jul 14, 2024 Issue: Budget/Appropriations Government Issues Health Issues
  • $70,000 Nov 03, 2023 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Science/Technology Health Issues
  • $140,000 Oct 20, 2023 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Science/Technology Health Issues
  • $160,000 Jul 20, 2023 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Science/Technology Health Issues
  • $150,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Science/Technology Health Issues
  • $140,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Science/Technology Health Issues
  • $170,000 Apr 20, 2022 Issue: Medicare/Medicaid Science/Technology Health Issues
  • $120,000 Jan 20, 2022 Issue: None
  • $170,000 Oct 20, 2021 Issue: None
  • $30,000 Jul 19, 2021 Issue: Health Issues
  • $90,000 Jul 18, 2021 Issue: Health Issues Government Issues
  • $30,000 Apr 20, 2021 Issue: Health Issues
  • $90,000 Apr 20, 2021 Issue: Health Issues Government Issues
  • $90,000 Jan 20, 2021 Issue: Budget/Appropriations Government Issues Health Issues
  • $30,000 Jan 19, 2021 Issue: Health Issues
  • $90,000 Oct 20, 2020 Issue: Health Issues Budget/Appropriations Government Issues
  • $90,000 Jul 19, 2020 Issue: Government Issues Health Issues

Former government officials who have lobbied for VIR

14 former government officials from 11 congressional offices at 3 lobbying firms have lobbied for VIR, most recently Jan 18, 2026.

  • Lucy McBath
    Michael Williams House New Legislative Director, Rep. Lucy McBath (2021-2022); Legislative Assistant, Rep. Lucy McBath (2019-2020); Legislative Aide, Sen. Doug Jones (2019); Legislative Correspondent, Sen. Doug Jones (2018-2019) Formerly with Lucy McBath · FORBES-TATE · Jan 18, 2026
  • Arthur Sidney House New LD & Chief Counsel, Rep. Jackson Lee (2008-2009); Chief of staff and chief counsel, Rep. Johnson (2009-2020) Formerly Jackson Lee · FORBES-TATE · Apr 15, 2024
  • Chuck Hagel
    Adrienne Schweer Senate New Chief of Protocol, Office of the Secretary of Defense (2014-2016); Senior Aide and Director of Scheduling, Sen. Chuck Hagel (2006-2008); Staff Assistant, Sen. Chuck Hagel (2005) Formerly with Chuck Hagel · FORBES-TATE · Jul 17, 2022
  • Paul Dioguardi Congress New Director, Office of Intergovernmental and External Affairs, U.S. Dept. of Health and Human Services (2009-2015); Chief of Staff, Office of Congressional and Intergovernmental Affairs, U.S. Dept. of Labor (1999-2001) Formerly Director, Office of Intergovernmental and External Affairs, U.S. Dept. of Health · FORBES-TATE · Jan 18, 2022
  • Douglas Stoss Congress New Cong. John Shadegg - Legislative Assistant, Subcommittee Staff Director, Chief of Staff, Policy Director; Centers for Medicare and Medicaid Services - Senior Counselor, Chief of Staff Formerly Cong. John Shadegg - Legislative Assistant, Subcommittee Staff Director, Chief o · VIR BIOTECHNOLOGY, INC. · Aug 25, 2021
  • Elijah E. Cummings
    Francesca Mccrary House New Legislative Assistant, Rep. Elijah Cummings (2016-2017); Professional Staff, House Oversight & Reform Committee (2016) Formerly with Elijah E. Cummings · FORBES-TATE · Jan 20, 2021
  • J. Dennis Hastert
    Darren Willcox House New ​Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director Formerly with J. Dennis Hastert · W STRATEGIES, LLC · Dec 03, 2020
  • Orrin G. Hatch
    Derrick White Senate New Deputy Communications Director, Sen. Orrin Hatch (2000-2001) Formerly with Orrin G. Hatch · FORBES-TATE · Jul 19, 2020
See all 14 on the Revolving Door dashboard

VIR Estimated quarterly lobbying spending

VIR Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
VIR Income Statement
VIR Balance Sheet
VIR Cash Flow
U.S. Patents

New VIR patent grants

  • Patent Title: Combination hbv therapy Sep. 02, 2025
  • Patent Title: Hiv vaccines comprising one or more population episensus antigens Apr. 18, 2023
  • Patent Title: Hiv vaccines comprising one or more population episensus antigens Jan. 17, 2023
  • Patent Title: Antibodies against sars-cov-2 and methods of using the same Oct. 25, 2022
  • Patent Title: Antibodies against sars-cov-2 and methods of using the same Nov. 09, 2021
  • Patent Title: Hiv vaccines comprising one or more population episensus antigens Jan. 19, 2021
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to VIR from public contracts

VIR News

Recent insights relating to VIR

CNBC Recommendations

Recent picks made for VIR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VIR

VIR Analyst Ratings

VIR Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
VIR Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $VIR stock a Buy, Sell, or Hold?

  • What is the price target for $VIR stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

VIR Top Shareholders
Shareholder
Shares Held
VIR Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $VIR stock?

  • Who owns the most shares of $VIR stock?

  • What funds own $VIR stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

VIR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view VIR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About VIR

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

  • Address San Francisco, CA
  • Market Cap 1.9 billion
  • Employees 367
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Vir Biotechnology, Inc. Common Stock (VIR) Historical Stock Prices

Vir Biotechnology, Inc. Common Stock (VIR) closed at $11.09 on September 23, 2026. Over the past year its adjusted close ranged from $5.12 to $11.63. Daily prices go back to October 11, 2019, 1,746 trading days in all.

  • 1 month+11.91%
  • 3 months+11.46%
  • Year to date+83.91%
  • 1 year+114.51%
  • 3 years+18.61%
  • 5 years-74.69%
  • Max-20.90%
See every congressional and insider trade on the VIR price chart

Quiver Premium charts VIR's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 11.44 11.53 10.85 11.09 11.09 1,685,268
Sep 22, 2026 10.99 11.72 10.88 11.50 11.50 1,852,669
Sep 21, 2026 10.77 10.95 10.66 10.88 10.88 1,454,929
Sep 18, 2026 10.92 11.00 10.44 10.60 10.60 7,017,421
Sep 17, 2026 10.87 11.21 10.68 10.92 10.92 1,794,367
Sep 16, 2026 10.54 10.67 10.39 10.52 10.52 2,091,090
Sep 15, 2026 10.71 10.72 10.23 10.44 10.44 2,284,809
Sep 14, 2026 10.73 10.94 10.64 10.77 10.77 1,841,514
Sep 11, 2026 10.79 10.95 10.38 10.62 10.62 2,077,968
Sep 10, 2026 10.57 10.79 10.45 10.58 10.58 1,855,270
Sep 9, 2026 11.04 11.38 10.73 10.81 10.81 1,945,669
Sep 8, 2026 11.22 11.28 10.99 11.18 11.18 1,613,924
Sep 4, 2026 11.31 11.64 11.18 11.38 11.38 1,152,060
Sep 3, 2026 11.54 11.62 11.07 11.45 11.45 2,565,558
Sep 2, 2026 11.63 11.94 11.35 11.50 11.50 3,019,931
Sep 1, 2026 10.80 11.74 10.80 11.63 11.63 2,778,728
Aug 31, 2026 10.77 11.17 10.65 10.94 10.94 3,046,561
Aug 28, 2026 11.16 11.46 10.79 10.83 10.83 1,835,260
Aug 27, 2026 11.00 11.46 10.84 11.31 11.31 1,737,396
Aug 26, 2026 10.60 11.12 10.30 11.08 11.08 2,248,635
Aug 25, 2026 10.03 11.28 9.97 10.71 10.71 2,961,369
Aug 24, 2026 9.74 9.97 9.44 9.91 9.91 1,739,718
Aug 21, 2026 9.31 9.86 9.30 9.78 9.78 1,756,469
Aug 20, 2026 9.61 9.71 9.03 9.21 9.21 1,060,645
Aug 19, 2026 9.86 10.08 9.54 9.77 9.77 2,085,738
Aug 18, 2026 9.27 9.50 9.24 9.49 9.49 1,480,848
Aug 17, 2026 9.23 9.49 9.17 9.39 9.39 1,460,798
Aug 14, 2026 9.00 9.27 8.80 9.24 9.24 1,016,284
Aug 13, 2026 9.02 9.20 8.88 9.00 9.00 1,246,431
Aug 12, 2026 8.89 9.09 8.86 8.96 8.96 984,213
Aug 11, 2026 8.96 9.01 8.77 8.93 8.93 1,203,155
Aug 10, 2026 8.80 9.03 8.79 8.89 8.89 1,487,216
Aug 7, 2026 8.87 9.03 8.75 8.82 8.82 1,663,129
Aug 6, 2026 9.70 9.70 8.62 8.77 8.77 2,602,609
Aug 5, 2026 9.19 9.36 9.00 9.11 9.11 1,452,638
Aug 4, 2026 9.02 9.28 8.93 9.17 9.17 1,708,608
Aug 3, 2026 8.91 9.06 8.54 8.90 8.90 1,241,592
Jul 31, 2026 8.95 8.96 8.54 8.66 8.66 1,126,891
Jul 30, 2026 8.61 8.99 8.61 8.90 8.90 1,197,371
Jul 29, 2026 8.84 8.97 8.55 8.64 8.64 1,412,840
Jul 28, 2026 8.83 8.88 8.52 8.85 8.85 1,391,470
Jul 27, 2026 8.82 9.09 8.77 8.80 8.80 1,687,972
Jul 24, 2026 9.00 9.15 8.62 8.69 8.69 2,151,596
Jul 23, 2026 9.21 9.47 9.16 9.34 9.34 1,514,525
Jul 22, 2026 9.38 9.59 9.30 9.35 9.35 1,451,570
Jul 21, 2026 9.20 9.55 9.14 9.42 9.42 1,731,755
Jul 20, 2026 9.40 9.59 9.11 9.23 9.23 1,475,249
Jul 17, 2026 9.31 9.64 9.22 9.43 9.43 1,739,895
Jul 16, 2026 9.54 9.70 9.12 9.40 9.40 1,955,116
Jul 15, 2026 9.49 9.66 9.32 9.61 9.61 1,225,213
Jul 14, 2026 9.74 9.77 9.47 9.49 9.49 1,676,037
Jul 13, 2026 9.81 9.91 9.52 9.72 9.72 1,914,217
Jul 10, 2026 10.32 10.45 9.63 9.96 9.96 1,676,911
Jul 9, 2026 10.43 10.58 10.22 10.34 10.34 1,285,226
Jul 8, 2026 10.14 10.53 10.04 10.43 10.43 1,952,005
Jul 7, 2026 10.17 10.34 9.87 10.25 10.25 1,352,430
Jul 6, 2026 9.97 10.18 9.74 10.02 10.02 1,569,881
Jul 2, 2026 9.64 10.10 9.58 10.04 10.04 1,159,890
Jul 1, 2026 10.18 10.32 9.51 9.56 9.56 1,905,078
Jun 30, 2026 10.41 10.54 10.14 10.19 10.19 1,724,863
Jun 29, 2026 10.11 10.47 10.09 10.38 10.38 1,935,344
Jun 26, 2026 9.89 10.32 9.88 10.03 10.03 7,498,725
Jun 25, 2026 9.90 10.23 9.85 9.88 9.88 1,337,061
Jun 24, 2026 10.23 10.38 9.94 9.95 9.95 2,369,444
Jun 23, 2026 9.39 10.18 9.39 10.16 10.16 2,534,153
Jun 22, 2026 9.29 9.63 9.16 9.57 9.57 1,793,644
Jun 18, 2026 9.43 9.81 9.01 9.16 9.16 8,795,300
Jun 17, 2026 8.68 9.37 8.68 9.30 9.30 3,000,584
Jun 16, 2026 8.62 8.73 8.49 8.61 8.61 1,377,850
Jun 15, 2026 8.73 8.86 8.53 8.61 8.61 1,397,694
Jun 12, 2026 8.68 8.86 8.52 8.61 8.61 1,177,219
Jun 11, 2026 8.31 8.63 8.26 8.52 8.52 1,371,838
Jun 10, 2026 8.46 8.65 8.16 8.25 8.25 1,707,654
Jun 9, 2026 8.62 8.73 8.24 8.51 8.51 1,657,919
Jun 8, 2026 8.74 8.92 8.39 8.45 8.45 1,332,806
Jun 5, 2026 9.09 9.19 8.63 8.65 8.65 1,327,726
Jun 4, 2026 8.91 9.29 8.91 9.15 9.15 1,444,561
Jun 3, 2026 8.87 9.03 8.68 8.77 8.77 2,375,221
Jun 2, 2026 8.94 9.02 8.73 8.74 8.74 1,415,189
Jun 1, 2026 9.34 9.49 9.02 9.03 9.03 1,749,218
May 29, 2026 9.51 9.91 9.47 9.54 9.54 3,089,702
May 28, 2026 9.02 9.64 8.86 9.55 9.55 2,325,323
May 27, 2026 9.45 9.54 9.08 9.10 9.10 1,392,390
May 26, 2026 9.24 9.57 9.16 9.38 9.38 1,154,005
May 22, 2026 9.07 9.29 9.03 9.19 9.19 1,209,273
May 21, 2026 8.78 9.18 8.70 9.03 9.03 957,438
May 20, 2026 8.64 8.98 8.60 8.88 8.88 1,934,456
May 19, 2026 8.69 8.83 8.52 8.53 8.53 1,867,040
May 18, 2026 8.77 8.87 8.54 8.77 8.77 1,515,946
May 15, 2026 8.96 8.98 8.64 8.79 8.79 1,714,436
May 14, 2026 9.34 9.39 8.92 9.09 9.09 1,555,814
May 13, 2026 9.37 9.45 9.16 9.33 9.33 1,215,810
May 12, 2026 9.32 9.57 9.19 9.40 9.40 1,236,112
May 11, 2026 9.15 9.64 9.12 9.29 9.29 1,833,483
May 8, 2026 9.31 9.54 9.11 9.12 9.12 1,611,671
May 7, 2026 9.86 9.91 9.18 9.27 9.27 2,788,391
May 6, 2026 10.09 10.31 9.99 10.29 10.29 1,594,048
May 5, 2026 10.33 10.45 9.90 10.01 10.01 1,038,417
May 4, 2026 10.07 10.25 9.98 10.18 10.18 1,443,679
May 1, 2026 10.22 10.43 9.94 10.00 10.00 1,050,633
Apr 30, 2026 10.18 10.42 10.16 10.21 10.21 1,167,598
Apr 29, 2026 10.15 10.22 9.94 10.08 10.08 1,308,078
Apr 28, 2026 10.71 10.90 10.17 10.28 10.28 1,653,444
Apr 27, 2026 10.37 10.74 10.24 10.64 10.64 1,848,002
Apr 24, 2026 10.59 10.64 10.00 10.37 10.37 1,262,580
Apr 23, 2026 10.69 10.80 10.27 10.35 10.35 1,241,388
Apr 22, 2026 10.85 10.96 10.52 10.67 10.67 2,405,710
Apr 21, 2026 11.10 11.18 10.76 10.83 10.83 1,409,727
Apr 20, 2026 10.62 11.66 10.56 11.09 11.09 2,595,680
Apr 17, 2026 10.60 10.76 10.26 10.75 10.75 2,355,140
Apr 16, 2026 10.50 10.60 10.24 10.33 10.33 1,253,178
Apr 15, 2026 10.00 10.47 9.95 10.46 10.46 2,238,445
Apr 14, 2026 9.35 10.09 9.35 10.05 10.05 2,698,351
Apr 13, 2026 9.12 9.58 9.06 9.31 9.31 1,651,338
Apr 10, 2026 9.87 9.90 9.41 9.50 9.50 1,408,323
Apr 9, 2026 9.50 9.95 9.50 9.83 9.83 2,107,617
Apr 8, 2026 9.47 9.71 9.20 9.52 9.52 2,512,437
Apr 7, 2026 9.01 9.19 8.78 9.17 9.17 1,612,411
Apr 6, 2026 8.92 9.27 8.92 9.06 9.06 1,356,453
Apr 2, 2026 8.66 9.40 8.65 9.06 9.06 1,727,274
Apr 1, 2026 9.10 9.24 8.87 9.02 9.02 2,087,214
Mar 31, 2026 8.65 9.06 8.64 8.96 8.96 1,995,339
Mar 30, 2026 8.40 8.47 8.26 8.46 8.46 1,487,823
Mar 27, 2026 8.91 8.99 8.39 8.40 8.40 1,459,176
Mar 26, 2026 8.90 9.18 8.86 8.96 8.96 2,030,404
Mar 25, 2026 8.76 9.39 8.65 8.99 8.99 2,440,648
Mar 24, 2026 8.75 8.77 8.51 8.57 8.57 1,889,388
Mar 23, 2026 9.12 9.24 8.79 8.84 8.84 2,039,523
Mar 20, 2026 9.35 9.47 9.05 9.10 9.10 3,933,109
Mar 19, 2026 9.18 9.55 9.08 9.38 9.38 1,969,323
Mar 18, 2026 9.47 9.48 8.98 9.32 9.32 2,827,704
Mar 17, 2026 9.69 9.76 9.44 9.48 9.48 2,262,189
Mar 16, 2026 9.29 9.85 9.28 9.68 9.68 2,201,236
Mar 13, 2026 9.61 9.73 9.12 9.26 9.26 2,612,536
Mar 12, 2026 9.76 9.76 9.31 9.48 9.48 3,784,269
Mar 11, 2026 9.86 10.29 9.67 9.82 9.82 3,825,789
Mar 10, 2026 9.92 10.00 9.62 9.88 9.88 3,246,469
Mar 9, 2026 9.44 10.05 9.36 9.80 9.80 3,308,477
Mar 6, 2026 8.90 9.62 8.67 9.55 9.55 4,013,509
Mar 5, 2026 9.35 9.57 9.06 9.10 9.10 2,487,570
Mar 4, 2026 9.20 9.81 9.04 9.56 9.56 4,444,971
Mar 3, 2026 9.05 9.17 8.75 8.91 8.91 4,602,270
Mar 2, 2026 8.85 10.09 8.82 9.34 9.34 10,583,316
Feb 27, 2026 9.29 9.50 8.89 9.09 9.09 5,399,537
Feb 26, 2026 8.91 9.47 8.71 9.32 9.32 21,339,234
Feb 25, 2026 9.82 10.94 9.76 10.00 10.00 10,250,345
Feb 24, 2026 9.84 10.29 8.95 9.49 9.49 38,364,275
Feb 23, 2026 7.54 7.79 7.26 7.43 7.43 12,322,601
Feb 20, 2026 7.68 7.81 7.51 7.56 7.56 1,065,590
Feb 19, 2026 7.74 7.87 7.50 7.82 7.82 1,773,511
Feb 18, 2026 7.45 7.88 7.40 7.83 7.83 1,766,715
Feb 17, 2026 7.56 7.82 7.40 7.50 7.50 1,416,802
Feb 13, 2026 7.79 7.89 7.38 7.47 7.47 1,285,546
Feb 12, 2026 7.41 7.72 7.10 7.71 7.71 1,594,489
Feb 11, 2026 7.49 7.54 7.08 7.42 7.42 1,383,050
Feb 10, 2026 7.25 7.67 7.16 7.51 7.51 1,837,540
Feb 9, 2026 7.19 7.28 7.01 7.28 7.28 1,181,715
Feb 6, 2026 7.06 7.40 7.04 7.19 7.19 1,864,842
Feb 5, 2026 7.35 7.50 6.86 6.92 6.92 1,268,363
Feb 4, 2026 7.64 7.68 7.08 7.50 7.50 1,853,995
Feb 3, 2026 7.71 7.97 7.46 7.68 7.68 1,041,506
Feb 2, 2026 7.33 7.83 7.25 7.71 7.71 1,475,270
Jan 30, 2026 7.74 7.89 7.41 7.44 7.44 1,904,468
Jan 29, 2026 7.51 7.80 7.50 7.78 7.78 1,142,746
Jan 28, 2026 7.68 7.80 7.38 7.57 7.57 2,115,045
Jan 27, 2026 7.45 7.79 7.42 7.69 7.69 1,150,696
Jan 26, 2026 7.43 7.57 7.12 7.45 7.45 1,596,599
Jan 23, 2026 7.45 7.75 7.24 7.56 7.56 3,480,295
Jan 22, 2026 6.99 7.57 6.99 7.40 7.40 2,801,480
Jan 21, 2026 5.99 6.98 5.97 6.94 6.94 3,048,752
Jan 20, 2026 5.91 6.15 5.79 6.00 6.00 1,692,264
Jan 16, 2026 6.22 6.25 6.03 6.06 6.06 1,672,416
Jan 15, 2026 6.81 6.89 6.18 6.20 6.20 2,047,809
Jan 14, 2026 6.31 6.90 6.29 6.82 6.82 2,903,703
Jan 13, 2026 5.90 6.40 5.84 6.31 6.31 2,397,954
Jan 12, 2026 5.89 5.95 5.69 5.92 5.92 1,435,220
Jan 9, 2026 6.01 6.09 5.79 5.85 5.85 1,317,026
Jan 8, 2026 6.05 6.12 5.87 5.95 5.95 1,433,660
Jan 7, 2026 6.03 6.29 5.93 6.16 6.16 1,995,613
Jan 6, 2026 5.79 6.07 5.69 5.96 5.96 2,373,550
Jan 5, 2026 5.94 6.02 5.55 5.79 5.79 1,976,813
Jan 2, 2026 6.03 6.10 5.84 5.94 5.94 1,224,449
Dec 31, 2025 5.82 6.07 5.78 6.03 6.03 1,499,724
Dec 30, 2025 5.94 6.12 5.75 5.84 5.84 1,015,469
Dec 29, 2025 5.92 6.00 5.88 5.98 5.98 1,114,566
Dec 26, 2025 6.06 6.09 5.89 6.00 6.00 1,212,277
Dec 24, 2025 6.01 6.16 5.92 6.11 6.11 771,739
Dec 23, 2025 6.00 6.06 5.85 5.99 5.99 1,299,364
Dec 22, 2025 5.79 6.11 5.75 6.01 6.01 2,052,717
Dec 19, 2025 5.97 6.06 5.73 5.76 5.76 5,157,102
Dec 18, 2025 6.20 6.33 5.92 5.93 5.93 2,099,969
Dec 17, 2025 6.53 6.75 6.00 6.14 6.14 2,841,637
Dec 16, 2025 6.68 6.70 6.36 6.48 6.48 1,600,426
Dec 15, 2025 6.77 6.97 6.69 6.72 6.72 1,267,061
Dec 12, 2025 6.65 6.85 6.58 6.69 6.69 1,212,093
Dec 11, 2025 6.55 6.83 6.50 6.63 6.63 1,510,364
Dec 10, 2025 6.69 6.89 6.49 6.55 6.55 1,778,858
Dec 9, 2025 6.51 6.88 6.51 6.66 6.66 1,515,573
Dec 8, 2025 6.90 7.06 6.50 6.58 6.58 1,918,256
Dec 5, 2025 6.79 6.83 6.21 6.50 6.50 1,870,764
Dec 4, 2025 6.17 6.92 6.11 6.78 6.78 3,524,567
Dec 3, 2025 5.64 6.29 5.60 6.27 6.27 2,391,446
Dec 2, 2025 5.80 5.95 5.45 5.63 5.63 2,268,272
Dec 1, 2025 6.22 6.29 5.86 6.07 6.07 2,720,502
Nov 28, 2025 6.41 6.54 6.33 6.42 6.42 813,271
Nov 26, 2025 6.35 6.50 6.25 6.39 6.39 1,892,359
Nov 25, 2025 6.28 6.61 6.12 6.44 6.44 2,646,588
Nov 24, 2025 5.76 6.31 5.68 6.12 6.12 2,712,296
Nov 21, 2025 5.56 5.79 5.47 5.68 5.68 967,040
Nov 20, 2025 5.56 5.75 5.46 5.56 5.56 1,784,343
Nov 19, 2025 5.46 5.57 5.32 5.44 5.44 1,571,477
Nov 18, 2025 5.39 5.60 5.36 5.50 5.50 1,063,271
Nov 17, 2025 5.56 5.70 5.45 5.49 5.49 1,084,325
Nov 14, 2025 5.36 5.86 5.36 5.63 5.63 1,259,609
Nov 13, 2025 5.65 5.70 5.43 5.47 5.47 1,126,466
Nov 12, 2025 5.70 5.84 5.67 5.71 5.71 1,319,053
Nov 11, 2025 5.35 5.74 5.33 5.71 5.71 1,187,355
Nov 10, 2025 5.30 5.42 5.22 5.37 5.37 1,570,414
Nov 7, 2025 5.11 5.16 4.82 5.13 5.13 1,693,266
Nov 6, 2025 5.13 5.63 4.97 5.12 5.12 1,657,215
Nov 5, 2025 5.16 5.41 5.13 5.40 5.40 1,105,962
Nov 4, 2025 5.51 5.52 5.20 5.25 5.25 1,506,974
Nov 3, 2025 5.91 5.97 5.50 5.60 5.60 1,523,592
Oct 31, 2025 5.87 5.98 5.76 5.96 5.96 1,006,327
Oct 30, 2025 5.81 6.12 5.79 5.93 5.93 1,320,163
Oct 29, 2025 6.45 6.50 5.87 5.91 5.91 1,517,347
Oct 28, 2025 6.15 6.55 6.14 6.43 6.43 1,649,252
Oct 27, 2025 5.98 6.20 5.92 6.19 6.19 986,625
Oct 24, 2025 5.85 6.03 5.81 5.98 5.98 1,415,169
Oct 23, 2025 6.09 6.19 5.75 5.78 5.78 4,663,286
Oct 22, 2025 6.21 6.29 6.08 6.12 6.12 1,292,976
Oct 21, 2025 6.28 6.44 6.12 6.27 6.27 1,009,610
Oct 20, 2025 5.96 6.30 5.80 6.27 6.27 1,697,497
Oct 17, 2025 5.76 5.95 5.71 5.78 5.78 1,072,151
Oct 16, 2025 6.10 6.17 5.79 5.80 5.80 1,024,290
Oct 15, 2025 5.73 6.08 5.70 6.07 6.07 1,228,725
Oct 14, 2025 5.87 5.87 5.71 5.72 5.72 632,671
Oct 13, 2025 5.84 5.95 5.72 5.86 5.86 783,629
Oct 10, 2025 6.00 6.11 5.73 5.80 5.80 1,196,636
Oct 9, 2025 6.07 6.38 5.96 6.04 6.04 2,419,494
Oct 8, 2025 5.69 6.33 5.61 6.05 6.05 3,504,091
Oct 7, 2025 5.58 5.67 5.52 5.66 5.66 875,982
Oct 6, 2025 5.73 5.83 5.57 5.59 5.59 874,532
Oct 3, 2025 5.71 5.83 5.36 5.73 5.73 1,748,907
Oct 2, 2025 5.70 5.72 5.42 5.66 5.66 1,227,669
Oct 1, 2025 5.72 6.00 5.64 5.70 5.70 1,243,540
Sep 30, 2025 5.62 5.79 5.47 5.71 5.71 1,219,402
Sep 29, 2025 5.51 5.64 5.36 5.63 5.63 1,026,725
Sep 26, 2025 5.18 5.51 5.15 5.49 5.49 2,085,602
Sep 25, 2025 5.20 5.32 5.14 5.18 5.18 967,007
Sep 24, 2025 5.21 5.37 5.18 5.26 5.26 1,211,784
Sep 23, 2025 5.32 5.33 5.13 5.17 5.17 748,434

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Vir Biotechnology, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at VIR, per a recent SEC DEF 14A filing. We estimate that the median employee at Vir Biotechnology, Inc. is paid $328,725.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation